Daniel Bunzol, M.D.
NPI 1831458181 · Physical Medicine & Rehabilitation Physician · Chicago, IL
Enrolled with Medicare as Practitioner - Physical Medicine and Rehabilitation · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1831458181
- Entity type
- Individual
- Primary specialty
- Physical Medicine & Rehabilitation PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 125.059440 (IL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
14 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
628 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 82 | $100 |
| Needle Measurement of Electrical Activity in Muscle With Injection of Chemical for Paralysis of Nerve Muscle95874 | 56 | $19 |
| Aspiration And/Or Injection of Fluid From Large Joint20610 | 53 | $60 |
| Injection of Chemical for Paralysis of Nerve Muscles on Arm Or Leg, 1-4 Muscles, Each Additional Extremity64643 | 43 | $72 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 43 | $137 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Baclofen | 115 | 35 |
| Gabapentin | 62 | 27 |
| Diclofenac Sodium | 37 | 11 |
| Duloxetine Hcl | 22 | — |
| Pregabalin | 19 | — |
| Meloxicam | 16 | — |
| Lidocaine | 15 | — |
| Tizanidine Hcl | 15 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$17 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2012-05-07
- Last updated
- 2015-06-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.